Alzheimer's disease, in the labyrinthine world of neuroscience where memories dance across synapses and consciousness remains ...
Most shocking to CARD workers was the termination of lead researcher Kendall Van Keuren-Jensen, who was announced internally ...
A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...
Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...
A hidden phase of Alzheimer’s appears decades before symptoms, offering a chance for early detection and treatment.
A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.
Researchers from the UK and Slovenia have identified disrupted brain-blood flow coordination and increased breathing rates as ...
Despite the potential benefits of early detection and increasing treatment options for Alzheimer's disease and related ...
Research by the ASU-Banner Neurodegenerative Research Center proposes that a common herpes virus may travel through the body ...
Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.
A medical research center named after former U.S. Sen. Roy Blunt of Missouri is facing drastic workforce reductions as part ...
Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...